PLoS Pathogens (Jul 2022)

Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.

  • Olivia Munoz,
  • Riddhima Banga,
  • Rachel Schelling,
  • Francesco Andrea Procopio,
  • Andrea Mastrangelo,
  • Pauline Nortier,
  • Khalid Ohmiti,
  • Jean Daraspe,
  • Matthias Cavassini,
  • Craig Fenwick,
  • Laurent Perez,
  • Matthieu Perreau

DOI
https://doi.org/10.1371/journal.ppat.1010673
Journal volume & issue
Vol. 18, no. 7
p. e1010673

Abstract

Read online

The limited development of broadly neutralizing antibodies (BnAbs) during HIV infection is classically attributed to an inadequate B-cell help brought by functionally impaired T follicular helper (Tfh) cells. However, the determinants of Tfh-cell functional impairment and the signals contributing to this condition remain elusive. In the present study, we showed that PD-L1 is incorporated within HIV virions through an active mechanism involving p17 HIV matrix protein. We subsequently showed that in vitro produced PD-L1high but not PD-L1low HIV virions, significantly reduced Tfh-cell proliferation and IL-21 production, ultimately leading to a decreased of IgG1 secretion from GC B cells. Interestingly, Tfh-cell functions were fully restored in presence of anti-PD-L1/2 blocking mAbs treatment, demonstrating that the incorporated PD-L1 proteins were functionally active. Taken together, the present study unveils an immunovirological mechanism by which HIV specifically exploits the regulatory potential of PD-L1 to suppress the immune system during the course of HIV infection.